当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第28期
编号:13446403
培美曲塞纳米制剂研究进展(5)
http://www.100md.com 2019年10月5日 《中国医药导报》 2019年第28期
     [21] Kü?觭üktürkmen B. Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells [J]. Drug Dev Ind Pharm,2018,44(2):306-315.

    [22] Lock LL,Li Y,Mao X,et al. One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents [J]. ACS Nano,2017,11(1):797-805.

    [23] Pangeni R,Choi JU,Panthi VK,et al. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations:preparation,characterization,and in vivo oral bioavailability and anticancer effect [J]. Int J Nanomedicine,2018,13:3329-3351.

    [24] Pangeni R,Panthi VK,Yoon IS,et al. Preparation,Characterization,and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin [J]. Pharmaceutics,2018,10(3).pii:E158.

    [25] Service RF. Nanotechnology.Nanoparticle Trojan horses gallop from the lab into the clinic [J]. Science,2010,330(6002):314-315.

    (收稿日期:2018-04-16 本文編辑:刘永巧), 百拇医药(凌建新 宁倩 唐圣松)
上一页1 2 3 4 5